Evolve Private Wealth LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 48,096 shares of the pharmacy operator's stock, valued at approximately $4,976,000.
Other large investors also recently made changes to their positions in the company. Kilter Group LLC bought a new stake in shares of CVS Health in the 2nd quarter valued at about $27,000. Beaird Harris Wealth Management LLC grew its holdings in CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp acquired a new position in CVS Health during the second quarter worth approximately $30,000. Dunhill Financial LLC bought a new stake in CVS Health in the second quarter valued at approximately $32,000. Finally, Swiss RE Ltd. acquired a new stake in shares of CVS Health in the fourth quarter valued at approximately $26,000. Institutional investors and hedge funds own 80.66% of the company's stock.
Analyst Ratings Changes
A number of research analysts recently weighed in on CVS shares. Morgan Stanley boosted their target price on CVS Health from $106.00 to $111.00 and gave the stock an "overweight" rating in a report on Thursday, June 4th. Robert W. Baird set a $107.00 price target on CVS Health in a report on Thursday, August 6th. HSBC reaffirmed a "hold" rating and set a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. TD Cowen increased their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a research report on Monday, May 11th. Finally, DA Davidson raised their target price on shares of CVS Health from $80.00 to $100.00 and gave the stock a "buy" rating in a research note on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $107.17.
Check Out Our Latest Research Report on CVS
CVS Health Trading Down 0.7%
Shares of CVS opened at $93.01 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The firm has a market cap of $118.96 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61. The business's fifty day moving average is $102.02 and its 200-day moving average is $88.86.
CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health's revenue was up 7.3% compared to the same quarter last year. During the same period last year, the firm posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.
CVS Health Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health's payout ratio is currently 70.37%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Recommended Stories
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
